SecBot SecBot

CRMD

CorMedix Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001410098 Biotech & Drug Discovery
$4.82 +0.16 (+3.43%)
Nov 16 4:00 PM ET · prev $4.66
Market cap
$385.0M
Small cap
Consensus
Buy
92% Buy or better · 12 analysts
Median target
$13.00
+170% · range $12.00–17.00
1 year
−51.7%
from $9.98 · Nov 17
30 days
−34.7%
from $7.38
52-week range
$4.66–12.73
−62% from high · low Nov 13
Avg volume 20D
2.12M
Oct 30 spike 7.01M
Short interest
14.21M
≈18.2% of shares · −3.1%
Days to cover
8.4
at average volume
Insider net
🔒 Subscribers only
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
17
analyzed by SecBot
SecBot read MIXED 9 reports · 90 days
Balance 1 bearish · 3 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 8/9

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersLOCKED

    1 open-market trade filed or updated in the last 24 hours. 🔒 Subscribers only.

  • InstitutionsBULLISH

    Q3 2026: 22 added (0 new), 10 trimmed or exited.

  • AnalystsBULLISH

    11 of 12 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.132 → −$0.160 over 90 days. 0 up, 2 down in 30 days.

  • Short sellersSTEADY

    Short interest −3.1% to 14.21M shares. 8.4 days to cover, ≈18.2% of shares.

  • TrendDOWNTREND

    32% below its 50-day average. New closing low $4.66 on Nov 13.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 8.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
AMERICAN CENTURY COMPANIES INCDOUBLED2,722,920$21.0M
MARSHALL WACE, LLPADD1,195,422$9.2M
MORGAN STANLEYADD641,157$4.9M
FIRST TRUST ADVISORS LPDOUBLED342,855$2.6M
JPMORGAN CHASE & CODOUBLED262,755$2.1M
Quantinno Capital Management LPADD197,568$1.5M
Private Advisor Group, LLCTRIM154,755$1.2M
LPL Financial LLCTRIM94,191$725.3K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12 analysts
Buy 92% rate it Buy or better
Strong Buy4Buy7Hold1Sell0Strong Sell0
12-month targets · 5 analysts

Price is below the lowest target. Median implies +170%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 13, 2026Oppenheimer
REITERATE
REITERATEOutperform
Nov 13, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Nov 12, 2026Needham
MAINTAIN
MAINTAINBuy
Nov 10, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Nov 10, 2026Needham
MAINTAIN
MAINTAINBuy
Nov 2, 2026Needham
MAINTAIN
MAINTAINBuy

Washington

Corporate Lobbying

9 lobbying filings and 6 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
🔒 Subscribers only
8 transactions
DateInsiderTypeValue
Nov 13, 2026🔒 Fresh data, subscribers only
Nov 13, 2026
BUY
Sep 18, 2026
Dillione Janet
Director
Sep 18, 2026
EXERCISE48,909 sh
Aug 29, 2026
Hurlburt Elizabeth
Chief Operating Officer
Aug 29, 2026
TAX W/H$67.0K
Aug 29, 2026
Blum Susan
Chief Financial Officer
Aug 29, 2026
TAX W/H$69.9K
Aug 29, 2026
Zelnick Kaufman Beth
Chief Legal Officer
Aug 29, 2026
TAX W/H$69.9K
Feb 4, 2026
Todisco Joseph
Chief Executive Officer
Feb 4, 2026
AWARD77,156 sh
Feb 4, 2026
Zelnick Kaufman Beth
Chief Legal Officer
Feb 4, 2026
AWARD36,006 sh
Feb 4, 2026
Hurlburt Elizabeth
Chief Operating Officer
Feb 4, 2026
AWARD36,006 sh

Earnings setup

Estimates
−$0.16
EPS estimate, this quarter
−21%
estimate change, 90 days
0↑ 2↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.16-$0.25–-$0.09-23.1%$51.6M
Next Q-$0.06-$0.06–-$0.06-200.0%$68.2M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
3 drugs tracked · Drug pipeline →
Recent

Short side

FINRA· Oct 30, 2026
14,205,973
shares short
-3.1%
vs prior settlement
8.4
days to cover
≈18.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Reddit
Recent posts
All social signals and their track records

SecBot reports

17 filings · 4 press releases · 8 bullish · 1 bearish · 8 neutral
All CRMD filing & press-release reports (21)